MyAverix Finance
NS · Healthcare
Transgene Biotek Ltd (526139)
Healthcare Services
Transgene Biotek Ltd (526139) is listed on NS in the Healthcare sector. Industry: Healthcare Services. As of 2026-07-10, reported market cap is $226.60M, P/E ratio is -13.59, net margin is -225.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 526139
Transgene Biotek Ltd (526139) — FAQ
What is Transgene Biotek Ltd's market cap?
Transgene Biotek Ltd (526139) has a reported market cap of $226.60M (data as of 2026-07-10).
What is 526139's P/E ratio?
The price-to-earnings (P/E) ratio for Transgene Biotek Ltd (526139) is -13.59 (data as of 2026-07-10).
Does Transgene Biotek Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Transgene Biotek Ltd (526139). Check the MyAverix Finance app for the latest dividend data.
What sector is Transgene Biotek Ltd in?
Transgene Biotek Ltd (526139) is classified in the Healthcare sector (Healthcare Services industry).
What exchange is 526139 listed on?
526139 is listed on NS.
What is Transgene Biotek Ltd's net margin?
Transgene Biotek Ltd (526139) reports a net margin of -225.6% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.